Mark Gross offers a case study in using structured product labeling (SPL) to reduce time to market.
Mark Gross
Advertisement
Mark Gross is CEO and founder of Data Conversion Laboratory (DCL) and a recognized authority on XML implementation and document conversion.
Articles by Mark Gross
Advertisement
Latest Updated Articles
Prastera: A Drug Listing Submission Case StudyPublished: March 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
